Volume 82, Issue 6, Pages (June 2014)

Slides:



Advertisements
Similar presentations
Schematic representation of the microRNA biogenesis machinery.
Advertisements

A Novel Cancer Therapeutic Using Thrombospondin 1 in Dendritic Cells
Myc‐induced miRNAs attenuate differentiation of c‐Myc‐depleted ES cells on LIF withdrawal. Myc‐induced miRNAs attenuate differentiation of c‐Myc‐depleted.
Volume 19, Issue 8, Pages (May 2017)
Volume 16, Issue 3, Pages (March 2015)
Volume 15, Issue 6, Pages (June 2012)
MicroRNA-31 Promotes Skin Wound Healing by Enhancing Keratinocyte Proliferation and Migration  Dongqing Li, X.I. Li, Aoxue Wang, Florian Meisgen, Andor.
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 6, Issue 5, Pages (May 2010)
Andrew Pollock, Shan Bian, Chao Zhang, Zhengming Chen, Tao Sun 
Volume 21, Issue 9, Pages (November 2017)
New Hope for a MicroRNA Therapy for Liver Cancer
MicroRNAs: regulators of gene expression and cell differentiation
Volume 82, Issue 1, Pages (April 2014)
The TRIM-NHL Protein TRIM32 Activates MicroRNAs and Prevents Self-Renewal in Mouse Neural Progenitors  Jens C. Schwamborn, Eugene Berezikov, Juergen A.
Volume 7, Issue 4, Pages (May 2014)
Volume 91, Issue 1, Pages (July 2016)
Volume 9, Issue 1, Pages (July 2017)
Rafael Kramann, Marcus J. Moeller  Kidney International 
Volume 31, Issue 6, Pages (December 2009)
Volume 8, Issue 4, Pages (April 2017)
Volume 79, Issue 6, Pages (September 2013)
Volume 9, Issue 2, Pages (February 2011)
Molecular Therapy - Nucleic Acids
Volume 84, Issue 6, Pages (December 2013)
Mutual Repression by Bantam miRNA and Capicua Links the EGFR/MAPK and Hippo Pathways in Growth Control  Héctor Herranz, Xin Hong, Stephen M. Cohen  Current.
HMGA2, MicroRNAs, and Stem Cell Aging
Wenqian Hu, Bingbing Yuan, Harvey F. Lodish  Developmental Cell 
Volume 24, Issue 2, Pages (July 2018)
Volume 50, Issue 3, Pages (May 2013)
Retinal Input Instructs Alignment of Visual Topographic Maps
Masato Yano, Yoshika Hayakawa-Yano, Aldo Mele, Robert B. Darnell 
Slicing-Independent RISC Activation Requires the Argonaute PAZ Domain
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 16, Issue 3, Pages (March 2015)
A Radial Glia-Specific Role of RhoA in Double Cortex Formation
Takashi Fukaya, Hiro-oki Iwakawa, Yukihide Tomari  Molecular Cell 
Volume 57, Issue 4, Pages (February 2008)
Volume 16, Issue 6, Pages (August 2016)
Expression of Alternative Ago2 Isoform Associated with Loss of microRNA-Driven Translational Repression in Mouse Oocytes  Jacob W. Freimer, Raga Krishnakumar,
Volume 25, Issue 4, Pages (February 2007)
Volume 7, Issue 6, Pages (December 2010)
Volume 70, Issue 5, Pages (June 2011)
Volume 48, Issue 2, Pages (October 2005)
MicroRNAs in cancer: biomarkers, functions and therapy
Volume 78, Issue 6, Pages (June 2013)
Volume 2, Issue 3, Pages (September 2012)
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
Molecular Therapy - Nucleic Acids
Volume 5, Issue 3, Pages (November 2013)
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells  Daphna Nachmani, Noam Stern-Ginossar,
Volume 27, Issue 6, Pages (September 2007)
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
Volume 13, Issue 12, Pages (December 2015)
Centrosome-Associated NDR Kinase Regulates Centrosome Duplication
Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease  Ryan L Boudreau,
Lin28 Mediates the Terminal Uridylation of let-7 Precursor MicroRNA
Volume 80, Issue 5, Pages (December 2013)
Volume 139, Issue 1, Pages (October 2009)
Characterization of NEX-CRE mice and analysis of Itgb1 expression by flow cytometry. a–n , Z/EG reporter mice carrying a CRE-inducible GFP transgene were.
MicroRNAs in cancer: biomarkers, functions and therapy
Boyan Bonev, Peter Stanley, Nancy Papalopulu  Cell Reports 
Doublecortin-like kinase Functions with doublecortin to Mediate Fiber Tract Decussation and Neuronal Migration  Hiroyuki Koizumi, Teruyuki Tanaka, Joseph.
Volume 33, Issue 1, Pages (July 2010)
Ryan L Boudreau, Inês Martins, Beverly L Davidson  Molecular Therapy 
A Novel Cancer Therapeutic Using Thrombospondin 1 in Dendritic Cells
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Volume 21, Issue 6, Pages (June 2012)
Chen Wu, Michelle E. Watts, Lee L. Rubin  Cell Reports 
Presentation transcript:

Volume 82, Issue 6, Pages 1255-1262 (June 2014) Off-Target Effect of doublecortin Family shRNA on Neuronal Migration Associated with Endogenous MicroRNA Dysregulation  Seung Tae Baek, Geraldine Kerjan, Stephanie L. Bielas, Ji Eun Lee, Ali G. Fenstermaker, Gaia Novarino, Joseph G. Gleeson  Neuron  Volume 82, Issue 6, Pages 1255-1262 (June 2014) DOI: 10.1016/j.neuron.2014.04.036 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Knockdown versus Knockout Discrepancy in Dcx and Dclk1 Mice Is at Least Partly due to Off-Target Effects of shRNA (A–C) DNA injected into the cerebral lateral ventricle (LV) at E14.5, electroporated into the ventricular zone (A, schematic, light blue), then GFP+ cell positions assessed at E18.5, dividing the cortex into upper, middle, and lower cortical plate regions (uCP, mCP, and loCP). In WT with empty GFP or Scrambled shRNA-GFP, most labeled cells were located in uCP (B and C). Scale bar, 100 μm. (D–F) Scrambled shRNA into Dcx knockout (KO) showed no defect (D), whereas Dcx 3′ UTR shRNA into either WT (E) or Dcx KO (F) showed a migration defect, with most cells in mCP and loCP. (G) Scrambled shRNA in WT or Dcx KO showed 55.6% versus 45.5% of cells in UCP. n = 4–6 mice from 2–4 litters for each condition. p >0.05, Student’s t test. Dcx 3′ UTR shRNA impaired migration in both the WT and Dcx KO, with 27.9% versus 10.3% of cells in UCP (∗∗∗p < 0.001). (H–K) Scrambled shRNA in Dclk1 KO (H) compared with Dclk1 shRNA in WT (I) versus Dclk1 KO (J). Quantification (K) showed 55.6% versus 56.4%, and 22.9% verssu 16.2% of cells in UCP, indicating an effect of the Dclk1 shRNA, irrespective of mouse genotype. n = 6–10 mice from 2–4 litters for each condition. See also Figure S1. Neuron 2014 82, 1255-1262DOI: (10.1016/j.neuron.2014.04.036) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Sequence-Dependent but Not Sequence-Specific Off-Target Effects of shRNAs (A–D) Dcx KO electroporated with scrambled (A) versus swapped loop (blue) maintaining Dcx 3′ UTR (B) or CDS stem sequence (C), showed migration defects (45.5% versus13.9% versus 19.0% of cells in uCP, ∗∗∗p < 0.001). Scale bar, 100 μm. (E–H) Compared with GFP alone (E), Severe (F), Moderate, or None (G) migration defects induced by a scrambled shRNAs. (H) Nine scrambled shRNAs electroporated into WT mice, ranked from most to least severe effects. The first four (a–d) showed the most dramatic differences (a–d, 32.1–43.1% in uCP, ∗∗∗p < 0.001), the next showed moderate difference (e, 51.3% in uCP, ∗p < 0.01), and last four were not significant (f–i, 51.3%–1.9%, ns) compared with GFP. n = 4–9 mice from 1–4 litters for each condition. See also Figure S2. Neuron 2014 82, 1255-1262DOI: (10.1016/j.neuron.2014.04.036) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 shmiRNA or siRNA Fail to Induce Off-Target Migration Defects (A) The pri-mRNA is cleaved in the nucleus by drosha/DGCR8 to yield pre-miRNA, which is akin to products from an shRNA vector, containing an antisense (red) and ∗ (green) strand, exported through the nuclear pore (space between ovals) by Exportin-5, further cleaved in the cytoplasm by Dicer to yield siRNAs, akin to synthetic siRNA duplex oligos, loaded onto RISC, and then guide strand associates with the target mRNA for silencing. (B–E) Dcx and Dclk1 miRNA are effective against endogenous Dcx (B and C) or Dclk1 (D–E) protein in transfected primary cortical neurons (green). Scale bar, 50 μm. (F–I) Dcx and Dclk1 shmiRNAs together but neither separately induces migration defect, comparing scrambled (F), Dcx (G), Dclk1 (H), and Dcx;Dclk1 (I) shmiRNA in WT brain. Scale bar, 100 μm. (J) Specificity and sensitivity of shmiRNAs targeting Dcx and Dclk1in WT cortex (71.0% Scrambled versus 69.2% Dcx shmiRNA1 versus 76.0% Dcx shmiRNA2 versus 70.9% Dclk1 shmiRNA versus 25.6% Dcx;Dclk1 shmiRNA KD of cells in UCP, ∗∗∗p < 0.001). n = 5–9 mice from each of 2 litters for each condition. See also Figure S3. Neuron 2014 82, 1255-1262DOI: (10.1016/j.neuron.2014.04.036) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 Disruption of Endogenous miRNA Processing Blocks Neuronal Migration (A–C) Dicerflox/flox Cre-GFP electroporated neurons fail neuronal migration. Cre-GFP into WT (A), GFP alone (B), or Cre-GFP into Dicerflox/flox show Dicer is required for migration. (D) Coelectroporation with Cre-reporter (DsRed2 expressing) demonstrates recombination. Scale bar, 100 μm. (E) Percent GFP+ cells in uCP. Defect only seen for Cre-GFP electroporation into Dicerflox/flox mice. ∗∗∗p < 0.001. n = 4–13 mice in 2 litters for each condition. (F) Following electroporation, VZ and loCP was microdissected at E16.5, cells dissociated, FACS isolated, and then miRNAs sequenced. (G) miRNAs with most severely dysregulated levels either reduced (red) or increased (green). The percent representation of each miRNA relative to total miRNAs identified (>20,000 reads). Formula to calculate the change (δ) in miRNA. (H and I) WT mice electroporated with GFP alone (H), Lin28-GFP (I, to interfere with let-7 family), and combination of miR9∗, 181a, and Lin28-GFP (J), showing progressive more severe migration defects. (K) Migration defects of combination electroporations, compared with Dcx shRNA. n = 5–10 mice from each of 1–4 litters for each condition. Neuron 2014 82, 1255-1262DOI: (10.1016/j.neuron.2014.04.036) Copyright © 2014 Elsevier Inc. Terms and Conditions